Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice - Wikidata - wikimedia - TriplyDB

Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

http://www.wikidata.org/entity/Q58761484

about

Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice

http://www.wikidata.org/entity/Q58761484

description

article

@en

im Jahr 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@en

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@nl

type

label

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@en

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@nl

prefLabel

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@en

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@nl

P1433

Q58761484-63E6BDEE-DD65-45BD-B7BE-3F693BA45D6B

P1476

Q58761484-49D0ED4B-9CA2-4391-BC86-3F1C15966451

P2093

Q58761484-0F98094B-7DD7-471A-85E3-6F863707E4CE

Q58761484-2EFAA835-56F8-4A15-A726-47F9E401B935

Q58761484-38BD0A87-779F-462D-9629-665AFB657E61

Q58761484-43A76A47-B5F8-4702-865C-6CE6E3CFF1B6

Q58761484-54517E62-BBB8-4988-85A9-E2E1D9D3230D

Q58761484-5B5C9B09-012B-4B07-9063-7D3CA9B9605A

Q58761484-6DC08737-B0E8-4412-87B6-7B5FEE5AB859

Q58761484-7AA2DD9D-9496-46C3-B644-4D25EE4E0E60

Q58761484-9EF7AA98-EA0D-483C-B9FA-F257A0A6E03B

Q58761484-B5B63950-DB1F-4A36-AD65-BC9955602D3F

P2860

Q58761484-01905189-4742-4E29-BF58-A2AB53F0AD37

Q58761484-0381A700-40CC-42BF-958E-53329E6B8E85

Q58761484-04F27B22-40A1-4694-9403-96C20BB0C1CA

Q58761484-07435A51-E7F9-4A92-A061-495764C1BBE5

Q58761484-0EF623F9-F9CD-4C37-B14D-FFBC47A2A9E6

Q58761484-118E0E3F-E369-4C81-B1D3-9C8198F00CAF

Q58761484-1570E51B-559A-4261-B10A-048F8FAC2898

Q58761484-212AFA8A-121F-4658-9EE0-3A3B163876BF

Q58761484-2ED56D47-005B-45B8-B895-351AE07C7503

Q58761484-322812DC-A4DA-4564-AE8B-0E63695D97F1

P304

Q58761484-9F2E1B44-C0E4-432F-86D9-A954FDDF504E

P31

Q58761484-453499AC-439C-45D7-A51A-2A85DE35FCD6

P356

Q58761484-1D84F188-2247-4E93-AE41-56117DC487C2

P407

Q58761484-14B0C0A4-D480-4D3F-B586-63E6D16D5728

P478

Q58761484-B8967671-3600-4E53-B4ED-068F3B6271FE

P577

Q58761484-8F3152C8-0DA7-4F4E-857E-CB0235488E74

P698

Q58761484-F6024EDE-AF6A-4D1A-A4DF-38191F912070

P921

Q58761484-4F9E646C-B115-481B-9CAB-01862EB67080

Q58761484-6551C7B6-3A53-43D1-AB5A-5335274B9A67

Q58761484-884516FD-D072-46D3-874B-2539091277E5

Q58761484-CFF55F1A-8649-4FE1-8124-3ABD1237306A

Q58761484-F669C08B-451C-4145-BAD4-082D0DD4F348

P932

Q58761484-FC985DB6-CA37-4EEB-9658-EFA317569D6C

P356

P1433

International Journal of Nanomedicine

P1476

Anti-JNK2 peptide-siRNA nanost ...... c risk in atherosclerotic mice

@en

P2093

Antonina Akk

http://www.w3.org/2001/XMLSchema#string

Christine Tn Pham

http://www.w3.org/2001/XMLSchema#string

Hua Pan

http://www.w3.org/2001/XMLSchema#string

Huimin Yan

http://www.w3.org/2001/XMLSchema#string

John Bacon

http://www.w3.org/2001/XMLSchema#string

Kirk K Hou

http://www.w3.org/2001/XMLSchema#string

Lihua Yang

http://www.w3.org/2001/XMLSchema#string

Luke E Springer

http://www.w3.org/2001/XMLSchema#string

Mark J Miller

http://www.w3.org/2001/XMLSchema#string

Paul H Schlesinger

http://www.w3.org/2001/XMLSchema#string

P2860

Quantifying progression and regression of thrombotic risk in experimental atherosclerosis

Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer

The protective effect of A20 on atherosclerosis in apolipoprotein E-deficient mice is associated with reduced expression of NF-kappaB target genes

STATs in cancer inflammation and immunity: a leading role for STAT3

Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy

Murine models of vascular thrombosis (Eitzman series).

Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.

Inflammation in atherosclerosis: from pathophysiology to practice

Interleukin-3/granulocyte macrophage colony-stimulating factor receptor promotes stem cell expansion, monocytosis, and atheroma macrophage burden in mice with hematopoietic ApoE deficiency

Quantifying the evolution of vascular barrier disruption in advanced atherosclerosis with semipermeant nanoparticle contrast agents.

P304

5187-5205

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IJN.S168556

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30233180

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

6135209

http://www.w3.org/2001/XMLSchema#string